THE SIGNIFICANCE OF CHROMOSOMAL TRANSLOCATION INVOLVING BCL6 GENE IN MALIGNANT LYMPHOMA
THE SIGNIFICANCE OF CHROMOSOMAL TRANSLOCATION INVOLVING BCL6 GENE IN MALIGNANT LYMPHOMA
批准号:
12670977
负责人:
MIKI Tohru
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We identified two regions in the BCL6 gene that negatively regulate BCL6 expression. One region, ES, is located within the first and a second region, IS, is located within the first intron. A consensus nucleotide sequence for the binding of the BCL6 protein itself was found within the ES. The IS region which is included in the regions commonly deleted in B-cell lymphomas had a silencer activity. Structural alterations of these two regions may play roles in the deregulated expression of the BCL6 gene in B-cell lymphomas.We report a case of non-Hodgkin's lymphoma of unknown origin with invasion into bone marrow and brain. Using FISH and SKY technique, we identified the new partner site of the 14q32 translocation, 22q13, and the jumping translocations involving 2p23 as a new donor chromosome. We could also identify the unbalanced translocation of t(3 ; 14)(q27 ; q32). The combination of SKY and FISH using the 14q telomere probe was therefore considered very useful for the characterization of complex cytogenetic cases in B-cell lymphoma.We cloned the human BAZF gene, homologue of protooncogene BCL6, using murine BAZF as a probe. The predicted amino acid sequence was 91% identical to that of murine BAZF. Fluorescence in situ hybridization analysis revealed that the human BAZF gene is located on chromosome 17p13.1. Although expression of human BAZF mRNA was ubiquitously detected in human tissues, abundant expression was detected in heart and placenta. BAZF mRNA was expressed in some immature B cell lines and erythroleukemia cell lines. The expression in a human erythroleukemia cell line, HEL cells, was upregulated during megakaryocytic differentiation induced by TPA.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kakazu N, Kito K, Hitomi T, Oita J, Nishida K, Matsuda K, Miki T, Abe T.: "Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using 14q t
Kakazu N、Kito K、Hitomi T、Oita J、Nishida K、Matsuda K、Miki T、Abe T.:“通过结合光谱核型分析 (SKY) 分析和荧光原位杂交来表征 B 细胞淋巴瘤中复杂的染色体异常
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakashita C, Fukuda T, Okabe S, Kobayashi H, Hirosawa S, Tokuhisa T, Miyasaka N, Miura O, Miki T.: "Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene"Biochem Biophys Res Commun. 291.3. 567-573 (2002)
Sakashita C、Fukuda T、Okabe S、Kobayashi H、Hirosawa S、Tokuhisa T、Miyasaka N、Miura O、Miki T.:“人类 BAZF 基因(BCL6 癌基因同源物)的克隆和表征”Biochem Biophys Res Commun。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kikuchi M.,Miki T.,Kumagai T.,Fukuda T.,Kamiyama R.,Miyasaka N.,Hirosawa S.: "Identification of negative regulatory regions within the first exon and intron of the BCL6 gene"Oncogene. 19・42. 4941-4945 (2000)
Kikuchi M.、Miki T.、Kumagai T.、Fukuda T.、Kamiyama R.、Miyasaka N.、Hirosawa S.:“BCL6 基因第一个外显子和内含子内负调控区域的鉴定”Oncogene 19・42。 .4941-4945 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kakazu N.Kito K.Hitomi T.Oita J.Nishida K.Masuda K.Miki T.Abe T.: "Characteiization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomer
Kakazu N.Kito K.Hitomi T.Oita J.Nishida K.Masuda K.Miki T.Abe T.:“通过结合光谱核型分析 (SKY) 分析和荧光原位杂交来表征 B 细胞淋巴瘤中复杂的染色体异常
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Functional modification of the transcription factor BCL6 by acetylation
-
批准号:14570966
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:MIKI Tohru
-
依托单位:
Analysis for transcriptional regulation of the BCL6 gene
-
批准号:09671098
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:MIKI Tohru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
USP37去泛素化稳定BCL6促进胰腺癌恶性生长的功能与机制研究
-
批准号:2026JJ81640
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘喜武
-
依托单位:
双硫仑靶向BCL6抑制弥漫大B细胞淋巴瘤的功能与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邢雅婧
-
依托单位:
BCL6调控线粒体稳态驱动巨噬细胞重编
程的分子机制及大黄蟅虫丸抗肝纤维化
的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:黄莎
-
依托单位:
超级增强子驱动的FOXQ1/BCL6互作轴促
进结直肠癌肝转移的作用与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:蒋利玲
-
依托单位:
转录因子BCL6对肿瘤组织浸润Treg细胞的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:黄启钊
-
依托单位:
ESM1通过抑制瘤内T细胞浸润及激活介导BCL6促肝癌免疫逃逸的分
子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李佳涛
-
依托单位:
LINC01518结合转录因子BCL6调控前列腺癌细胞睾酮代谢的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
BCL6调控巨噬细胞代谢重编程在细菌性脓毒症中的作用及机制研究
-
批准号:LY23H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:赵冬久
-
依托单位:
益气养阴祛瘀方通过KDM4C介导的Bcl6启动子区组蛋白修饰干预SS Tfh分化的机制研究
-
批准号:82374402
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王新昌
-
依托单位:
BCL6调控PKM2介导的糖代谢重编程在腹主动脉瘤中的作用和机制研究
-
批准号:82300550
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张颢
-
依托单位: